Sygnature Discovery Limited
2 followers
‌
Sygnature Discovery are a leading drug discovery CRO with expertise across a range of therapeutic and biological target classes. An expert partner in disciplines including Medicinal and Computational Chemistry, In Vitro and In Vivo Pharmacology, DMPK, supported by informatics.
Org chart
Simon Hirst
Collapse
Paul Overton
CCO & Director
Jonathan Williams
COO & Director
Louisa Jordison
CFO & Director
James Edgar
Chief People Officer
David Witty
Chief Scientific Officer
Allan Jordan
VP, Oncology Drug Discovery
John Unitt
VP, Immunology & Inflammation Drug Discovery
Max Mirza
VP, Neuroscience Drug Discovery
Stephen Young
VP, Hit ID Technologies
Emily Eaton
VP, Commercial Services
Geraint Jones
Director of Chemistry
Colin Sambrook Smith
Director of Computational Sciences & Informatics
Jane Kendrew
Director of Translational Oncology
Dave Pearson
Director, Form & Formulation
Alex Stevens
Director DMPK
Claire Ellis-Ross
Manager Of Internal Communications
Amelia Taibon-Kuer
Senior Scientist 2
Amy Cantrell
Senior Scientist
Aparna Chandrasekaran
Senior Scientist
Arundhati Dongre
Senior Scientist
Clare Wilson
Senior Scientist
Dr. Gopi Krishna Reddy Alavala
Senior Scientist - I
Hannah Warren
Senior Scientist 2
Indranil Duttagupta
Lead Scientist
James Engleback
Senior Scientist
Katarzyna Kopycka
Senior Scientist 1
Martin Lau Christiansen
Senior Scientist
Marketing Coordinator
Vacant position
